1
|
Murueta-Goyena A, Andikoetxea A, Gómez-Esteban JC, Gabilondo I. Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson's Disease. Front Pharmacol 2019; 10:1294. [PMID: 31736763 PMCID: PMC6831739 DOI: 10.3389/fphar.2019.01294] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2019] [Accepted: 10/09/2019] [Indexed: 12/13/2022] Open
Abstract
Non-motor symptoms are common in Parkinson’s disease (PD) and they represent a major source of disease burden. Several non-motor manifestations, such as rapid eye movement sleep behavior disorder, olfactory loss, gastrointestinal abnormalities, visual alterations, cognitive and mood disorders, are known to precede the onset of motor signs. Nonetheless, the mechanisms mediating these alterations are poorly understood and probably involve several neurotransmitter systems. The dysregulation of GABAergic system has received little attention in PD, although the spectrum of non-motor symptoms might be linked to this pathway. This Mini Review aims to provide up-to-date information about the involvement of the GABAergic system for explaining non-motor manifestations in early stages of PD. Therefore, special attention is paid to the clinical data derived from patients with isolated REM sleep behavior disorder or drug-naïve patients with PD, as they represent prodromal and early stages of the disease, respectively. This, in combination with animal studies, might help us to understand how the disturbance of the GABAergic system is related to non-motor manifestations of PD.
Collapse
Affiliation(s)
- Ane Murueta-Goyena
- Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain
| | - Ane Andikoetxea
- Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain
| | - Juan Carlos Gómez-Esteban
- Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.,Department of Neuroscience, University of the Basque Country (UPV/EHU), Leioa, Spain
| | - Iñigo Gabilondo
- Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.,IKERBASQUE Basque Foundation for Science, Bilbao, Spain
| |
Collapse
|
2
|
Yang XQ, Lauzon B, Seergobin KN, MacDonald PA. Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson's Disease. Front Hum Neurosci 2018; 11:642. [PMID: 29354045 PMCID: PMC5758505 DOI: 10.3389/fnhum.2017.00642] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2017] [Accepted: 12/18/2017] [Indexed: 11/13/2022] Open
Abstract
Parkinson's disease (PD) is characterized by resting tremor, rigidity and bradykinesia. Dopaminergic medications such as L-dopa treat these motor symptoms, but can have complex effects on cognition. Impulse control is an essential cognitive function. Impulsivity is multifaceted in nature. Motor impulsivity involves the inability to withhold pre-potent, automatic, erroneous responses. In contrast, cognitive impulsivity refers to improper risk-reward assessment guiding behavior. Informed by our previous research, we anticipated that dopaminergic therapy would decrease motor impulsivity though it is well known to enhance cognitive impulsivity. We employed the Go/No-go paradigm to assess motor impulsivity in PD. Patients with PD were tested using a Go/No-go task on and off their normal dopaminergic medication. Participants completed cognitive, mood, and physiological measures. PD patients on medication had a significantly higher proportion of Go trial Timeouts (i.e., trials in which Go responses were not completed prior to a deadline of 750 ms) compared to off medication (p = 0.01). No significant ON-OFF differences were found for Go trial or No-go trial response times (RTs), or for number of No-go errors. We interpret that dopaminergic therapy induces a more conservative response set, reflected in Go trial Timeouts in PD patients. In this way, dopaminergic therapy decreased motor impulsivity in PD patients. This is in contrast to the widely recognized effects of dopaminergic therapy on cognitive impulsivity leading in some patients to impulse control disorders. Understanding the nuanced effects of dopaminergic treatment in PD on cognitive functions such as impulse control will clarify therapeutic decisions.
Collapse
Affiliation(s)
- Xue Q. Yang
- MacDonald Lab, Brain and Mind Institute, University of Western Ontario, London, ON, Canada
| | - Brian Lauzon
- MacDonald Lab, Brain and Mind Institute, University of Western Ontario, London, ON, Canada
| | - Ken N. Seergobin
- MacDonald Lab, Brain and Mind Institute, University of Western Ontario, London, ON, Canada
| | - Penny A. MacDonald
- MacDonald Lab, Brain and Mind Institute, University of Western Ontario, London, ON, Canada
- Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada
| |
Collapse
|
3
|
Novelty processing and memory formation in Parkinson׳s disease. Neuropsychologia 2014; 62:124-36. [DOI: 10.1016/j.neuropsychologia.2014.07.016] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2014] [Revised: 06/05/2014] [Accepted: 07/16/2014] [Indexed: 01/25/2023]
|
4
|
Botha H, Carr J. Attention and visual dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2012; 18:742-7. [PMID: 22503538 DOI: 10.1016/j.parkreldis.2012.03.004] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/05/2011] [Revised: 03/05/2012] [Accepted: 03/06/2012] [Indexed: 10/28/2022]
Abstract
Visual processing extends from the retinal level to the ventral temporal lobe, and is modified by top-down and bottom-up processing. Complex visual hallucinations (VH) are commonly a feature of disorders which affect temporal lobe structures, frequently in association with impairment of ascending monoaminergic pathways. When Parkinson's disease (PD) is associated with VH, pathological changes characteristically affect the temporal lobes, a finding which is recapitulated by imaging findings. However, a major association of VH is with cognitive decline, and this is typically linked to deficits in attention and working memory, both of which are modulated by dopamine. Similarly, dopamine plays a crucial role in the function of prefrontal cortex, in addition to controlling access to consciousness via gating mechanisms that are dependent on the basal ganglia.
Collapse
Affiliation(s)
- Hugo Botha
- Division of Neurology, Department of Medicine, Faculty of Health Sciences, University of Stellenbosch, PO Box 19063, Tygerberg 7505, Cape Town, South Africa
| | | |
Collapse
|
5
|
Arnott WL, Copland DA, Chenery HJ, Murdoch BE, Silburn PA, Angwin AJ. The influence of dopamine on automatic and controlled semantic activation in Parkinson's disease. PARKINSONS DISEASE 2011; 2011:157072. [PMID: 22135759 PMCID: PMC3216283 DOI: 10.4061/2011/157072] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/12/2011] [Revised: 09/15/2011] [Accepted: 09/26/2011] [Indexed: 12/04/2022]
Abstract
Two semantic priming
tasks, designed to isolate automatic and
controlled semantic activation, were utilized to
investigate the impact of dopamine depletion on
semantic processing in Parkinson's disease
(PD). Seven people with PD (tested whilst on and
off levodopa medication) and seven healthy
adults participated in the study. The healthy
adult participants demonstrated intact automatic
and controlled semantic activation. Aberrant
controlled semantic activation was observed in
the PD group on levodopa; however, automatic
semantic activation was still evident. In
contrast, automatic semantic activation was not
evident in the PD group off levodopa. These
results further clarify the impact of PD on
semantic processing, demonstrating that dopamine
depletion can cause disturbances in both
automatic and controlled semantic
activation.
Collapse
Affiliation(s)
- Wendy L Arnott
- School of Health and Rehabilitation Sciences, University of Queensland, Brisbane, QLD 4072, Australia
| | | | | | | | | | | |
Collapse
|
6
|
Butler PM, McNamara P, Ghofrani J, Durso R. Disease-associated differences in religious cognition in patients with Parkinson's disease. J Clin Exp Neuropsychol 2011; 33:917-28. [DOI: 10.1080/13803395.2011.575768] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Paul M. Butler
- a Department of Neurology , Boston University School of Medicine , Boston, MA, USA
- b Department of Neurology , VA Boston Healthcare System , Boston, MA, USA
| | - Patrick McNamara
- a Department of Neurology , Boston University School of Medicine , Boston, MA, USA
- b Department of Neurology , VA Boston Healthcare System , Boston, MA, USA
| | - Jessica Ghofrani
- c Department of Neuroscience , College of Arts & Sciences, Boston University , Boston, MA, USA
| | - Raymon Durso
- a Department of Neurology , Boston University School of Medicine , Boston, MA, USA
- b Department of Neurology , VA Boston Healthcare System , Boston, MA, USA
| |
Collapse
|
7
|
Macdonald PA, Monchi O. Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function. PARKINSONS DISEASE 2011; 2011:572743. [PMID: 21437185 PMCID: PMC3062097 DOI: 10.4061/2011/572743] [Citation(s) in RCA: 69] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 11/21/2010] [Accepted: 01/07/2011] [Indexed: 11/20/2022]
Abstract
Cognitive abnormalities are a feature of Parkinson's disease (PD). Unlike motor symptoms that are clearly improved by dopaminergic therapy, the effect of dopamine replacement on cognition seems paradoxical. Some cognitive functions are improved whereas others are unaltered or even hindered. Our aim was to understand the effect of dopamine replacement therapy on various aspects of cognition. Whereas dorsal striatum receives dopamine input from the substantia nigra (SN), ventral striatum is innervated by dopamine-producing cells in the ventral tegmental area (VTA). In PD, degeneration of SN is substantially greater than cell loss in VTA and hence dopamine-deficiency is significantly greater in dorsal compared to ventral striatum. We suggest that dopamine supplementation improves functions mediated by dorsal striatum and impairs, or heightens to a pathological degree, operations ascribed to ventral striatum. We consider the extant literature in light of this principle. We also survey the effect of dopamine replacement on functional neuroimaging in PD relating the findings to this framework. This paper highlights the fact that currently, titration of therapy in PD is geared to optimizing dorsal striatum-mediated motor symptoms, at the expense of ventral striatum operations. Increased awareness of contrasting effects of dopamine replacement on dorsal versus ventral striatum functions will lead clinicians to survey a broader range of symptoms in determining optimal therapy, taking into account both those aspects of cognition that will be helped versus those that will be hindered by dopaminergic treatment.
Collapse
Affiliation(s)
- Penny A Macdonald
- Department of Neurology & Neurosurgery, McGill University, Montreal, QC, Canada
| | | |
Collapse
|
8
|
Arnott WL, Chenery HJ, Angwin AJ, Murdoch BE, Silburn PA, Copland DA. Decreased semantic competitive inhibition in Parkinson's disease: Evidence from an investigation of word search performance. INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY 2010; 12:437-445. [PMID: 20602578 DOI: 10.3109/17549507.2010.492875] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
Aberrant semantic competitive inhibition has been reported in Parkinson's disease (PD). Whether PD-related alterations cause an increase or a decrease in lateral inhibition, however, remains unclear. Accordingly, the present study aimed to examine semantic inhibition during lexical-semantic processing in non-demented people with PD. Twenty-two people with PD and 18 matched controls completed a computerized word search task in which both the relationship between the background items and the target (related or unrelated) and the search type (open e.g., any dog or closed e.g., collie) were manipulated. It was hypothesized that decreased semantic inhibition would be evidenced by abnormally short response times for open searches among words related to the target, while increased inhibition would lead to abnormally long response times. Analysis of the results revealed that control participants performed open searches faster for unrelated vs related word lists. In contrast, the PD group recorded similar response times regardless of background items. Hence, the present findings are consistent with the notion of decreased semantic competitive inhibition in PD and suggest that an impaired ability to inhibit unwanted information during lexical retrieval may underlie observed deficits on semantic tasks such as verbal fluency.
Collapse
|
9
|
Emotion and object processing in Parkinson’s disease. Brain Cogn 2010; 72:457-63. [DOI: 10.1016/j.bandc.2010.01.001] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2009] [Revised: 12/20/2009] [Accepted: 01/12/2010] [Indexed: 11/19/2022]
|
10
|
Disruption of the prefrontal cortex function by rTMS produces a category-specific enhancement of the reaction times during visual object identification. Neuropsychologia 2008; 46:2725-31. [DOI: 10.1016/j.neuropsychologia.2008.05.004] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2008] [Revised: 05/05/2008] [Accepted: 05/08/2008] [Indexed: 11/21/2022]
|